Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

By A. Rush, H. Kraemer, H. Sackeim, Maurizio Fava, Madhukar H. Trivedi, E. Frank, P. Ninan, M. Thase, A. Gelenberg, David J. Kupfer and 4 more. Neuropsychopharmacology, 2006

673 citations recorded by the source corpus.

Subfields: Experimental and Cognitive Psychology, Pharmacology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/c7f883a0b00585f333510eb03e4b433bf4685cb5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Experimental and Cognitive Psychology

1. C. Brewin
2. P. Fisher
3. T. Patel
4. Samuel G. Myers
5. J. Wheatley
6. A. Wells
7. Julie D. Golomb
8. Marvin M. Chun

In Pharmacology

1. Maurizio Fava

In Psychiatry and Mental health

1. A. Wells
2. Julie D. Golomb
3. Marvin M. Chun

Citations in the corpus

• Enhanced visual motion perception in Major Depressive Disorder (2009, background): “All patients had been medication-free and euthymic for a minimum of 4 months to meet criteria for recovery as per guidelines (Rush et al., 2006).”
• The STAR*D project results: A comprehensive review of findings (2007, background): “ment [7,8] because remitters function better [9] and have a better prognosis [10] than those who respond (have a symptom reduction) without remitting.”
• Metacognitive Therapy in Recurrent and Persistent Depression: A Multiple-Baseline Study of a New Treatment (2009, methodology): “Rush et al. (2006) define recovery as 4 months with a HRSD17 score of B7 when patients are assessed every 2-weeks.”